Gastrinomas are the first presentation of MEN1 in 29–40% of patients; in most cases the patient will already have developed hyperparathyroidism which has not yet been diagnosed [42–44]. The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.